FDA clears AI-powered prostate cancer detection softwareSoftware that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by Share XFDA clears AI-powered prostate cancer detection softwarehttps://pharmaphorum.com/news/fda-clears-ai-powered-prostate-cancer-detection-software/
AI aims to prevent unneeded treatment for deep vein thrombosisResearchers in the UK are working on an artificial intelligence (AI) algorithm to help diagnose deep vein thrombosis Share XAI aims to prevent unneeded treatment for deep vein thrombosishttps://pharmaphorum.com/news/ai-aims-to-prevent-unneeded-treatment-for-deep-vein-thrombosis/
J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ techThree years ago, Johnson & Johnson set up a wide-ranging initiative with Boston University to try to improve Share XJ&J lung cancer initiative will use Optellum’s ‘digital biomarker’ techhttps://pharmaphorum.com/news/jj-teams-up-with-optellum-on-digital-biomarker-tech-lung-cancer/
UK adults asked to record coughs to improve COVID detectionResearchers in the UK are asking adults who have taken a COVID-19 test in the last 72 hours Share XUK adults asked to record coughs to improve COVID detectionhttps://pharmaphorum.com/news/uk-adults-asked-to-record-coughs-to-improve-covid-detection/
FDA grants swift approval to Cognoa’s digital device for autism diagnosisThe FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum Share XFDA grants swift approval to Cognoa’s digital device for autism diagnosishttps://pharmaphorum.com/news/fda-grants-swift-approval-to-cognoas-digital-device-for-autism-diagnosis/
UK hospital deploys Microsoft AI to tackle cancer backlogAddenbrooke’s Hospital in Cambridge will be the first in the world to use an artificial intelligence tool developed Share XUK hospital deploys Microsoft AI to tackle cancer backloghttps://pharmaphorum.com/news/uk-hospital-deploys-microsoft-ai-to-tackle-cancer-backlog/
Cognoa preps FDA filing for digital autism diagnosticAn artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in Share XCognoa preps FDA filing for digital autism diagnostichttps://pharmaphorum.com/news/cognoa-preps-fda-filing-for-digital-autism-diagnostic/
Illumina wants to bring liquid biopsy spinout Grail back in-house; reportCancer diagnosis firm Grail could be re-joining Illumina, the company it was spun out of in 2016, despite Share XIllumina wants to bring liquid biopsy spinout Grail back in-house; reporthttps://pharmaphorum.com/news/illumina-wants-to-bring-liquid-biopsy-spinout-grail-back-in-house-report/
UK medical journals spar over breast cancer screening studyScreening women for breast cancer in their 40s rather than their 50s could save lives, say the authors Share XUK medical journals spar over breast cancer screening studyhttps://pharmaphorum.com/news/uk-medical-journals-spar-over-breast-cancer-screening-study/
